Skip to content
Menu

Nektar Therapeutics NKTR

Full chart Compare
Set alert

Price alert · NKTR

All alert types
30.20 USD -2.34 (-7.19%)

Regular-session close

30.20 0.00 0.00%

After hours · Nov 20, 4:38 PM ET

30.13 Day range 32.35
30.13 52-week range 109.00
YTD
-28.57%
1 year
-45.20%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Income Tax Benefit$138.00KGross Profit$55.23MNet Loss$164.08MExpenses$219.45MSelling, General & Admin$68.67MResearch & Development$117.33MInterest Expense$26.18MOther Expenses$7.26MRevenue$55.23MNon Cash Royalty Revenue Related To Sale Of Future Royalties$54.93MLicense Collaboration And Other Revenue$300.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

NKTR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
55.23M98.43M90.12M92.06M101.91M
55.23M67.74M56.35M70.42M77.01M
-140.10M-105.20M-263.68M-376.17M-446.10M
-164.08M-118.96M-276.06M-368.20M-523.84M
-9.73-8.68-21.70-29.50-42.90
NKTR annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
15.12M44.25M35.28M88.23M25.22M
280.41M303.85M398.03M710.60M1.12B
190.57M243.11M267.05M343.96M437.68M
85.75M102.56M117.78M131.50M143.18M
89.83M60.74M130.99M366.64M679.51M
NKTR annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-208.51M-175.71M-192.61M-304.01M-412.66M
-1.20M142.57M139.56M365.83M202.78M
180.57M42.12M30.00K1.51M36.24M
-868.00K63.92M380.00K7.52M-14.99M
-29.14M8.97M-52.95M63.01M-173.74M